IL18 and gout: Its main clinical manifestations are hyperuricemia and joint pain.1 The complex pathogenesis of gout is generally thought to be regulated by proinflammatory cytokines, including tumor necrosis factor (TNF-α), interleukin (IL)-6, IL-18, and IL-1β.